Allworth Financial LP Biomea Fusion, Inc. Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 4 shares of BMEA stock, worth $5. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$5% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
100Shares Held
23.2MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$5.03 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$4.68 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.07 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$2.68 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.46 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $38.4M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...